JPML Centralizes Insulin Price-Fixing Suits In New Jersey
The Judicial Panel of Multidistrict Litigation has sent five state cases against insulin manufacturers such as Eli Lilly and pharmacy benefit managers including CVS to the District of New Jersey, ruling...To view the full article, register now.
Already a subscriber? Click here to view full article